GondolaBio
Develops clinical-stage therapeutics for rare genetic diseases.
biotechpharmaceuticals
Company facts
- Founded
- 2024
- Employees
- 45
- Headquarters
- United States
- Type
- Private
- Funding
- Corporate Round · $300M · 2024
- Subsidiaries
- Portal Therapeutics
Open positions
2 jobs
5 views 3 months ago
Senior Director, Clinical Operations
Open 69d HybridNorth AmericaSenior
United States
Palo Alto, CA- HybridAbout GondolaBio GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally…
7 views 3 months ago
Senior Manager, Patient Advocacy
Open 69d HybridNorth AmericaSenior
United States
Palo Alto, CA- HybridCOMPANY BACKGROUND GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio,…